Advertisement
GKOS vs NTRA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GKOS is a Hold and NTRA is a Hold.
GKOS in downward trend: price dove below 50-day moving average on September 16, 2026
GKOS moved below its 50-day moving average on September 16, 2026 date and that indicates a change from an upward trend to a downward trend. In 29 of 36 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 81%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for GKOS crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GKOS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
GKOS broke above its upper Bollinger Band on October 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for GKOS entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GKOS's RSI Oscillator exited the oversold zone, 16 of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on GKOS as a result. In 76 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for GKOS just turned positive on October 02, 2026. Looking at past instances where GKOS's MACD turned positive, the stock continued to rise in 47 of 59 cases over the following month. The odds of a continued upward trend are 80%.
Following a +4.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where GKOS advanced for three days, in 250 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 37 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. GKOS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 46 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.246) is normal, around the industry mean (2.949). P/E Ratio (-50.410) is within average values for comparable stocks, (2.438). Projected Growth (PEG Ratio) (12.570) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (15.456) is also within normal values, averaging (40.124).
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Aroon Indicator for NTRA shows an upward move is likely
NTRA's Aroon Indicator triggered a bullish signal on October 15, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 286 similar instances where the Aroon Indicator showed a similar pattern. In 239 of the 286 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 55 cases where NTRA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
Following a +4.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where NTRA advanced for three days, in 241 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Bearish Trend Analysis
The 10-day RSI Indicator for NTRA moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 27 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NTRA as a result. In 75 of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for NTRA turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 36 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 72%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NTRA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
NTRA broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (31.135) is normal, around the industry mean (63.879). NTRA's P/E Ratio (-291.437) is considerably lower than the industry average of (1.769). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (17.857) is also within normal values, averaging (9.775).
The Tickeron Profit vs. Risk Rating rating for this company is 11 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 32 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. NTRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
GKOS | NTRA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 21 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 91 Overvalued | 6 Undervalued | |
PROFIT vs RISK RATING 1..100 | 37 | 11 | |
SMR RATING 1..100 | 96 | 94 | |
PRICE GROWTH RATING 1..100 | 38 | 34 | |
P/E GROWTH RATING 1..100 | 46 | 32 | |
SEASONALITY SCORE 1..100 | 50 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NTRA's Valuation (6) in the Biotechnology industry is significantly better than the same rating for GKOS (91) in the Medical Specialties industry. This means that NTRA’s stock grew significantly faster than GKOS’s over the last 12 months.
NTRA's Profit vs Risk Rating (11) in the Biotechnology industry is in the same range as GKOS (37) in the Medical Specialties industry. This means that NTRA’s stock grew similarly to GKOS’s over the last 12 months.
NTRA's SMR Rating (94) in the Biotechnology industry is in the same range as GKOS (96) in the Medical Specialties industry. This means that NTRA’s stock grew similarly to GKOS’s over the last 12 months.
NTRA's Price Growth Rating (34) in the Biotechnology industry is in the same range as GKOS (38) in the Medical Specialties industry. This means that NTRA’s stock grew similarly to GKOS’s over the last 12 months.
NTRA's P/E Growth Rating (32) in the Biotechnology industry is in the same range as GKOS (46) in the Medical Specialties industry. This means that NTRA’s stock grew similarly to GKOS’s over the last 12 months.
| GKOS | NTRA | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 84% | 3 days ago 71% |
| Stochastic ODDS (%) | 3 days ago 72% | 3 days ago 82% |
| Momentum ODDS (%) | 3 days ago 82% | 3 days ago 75% |
| MACD ODDS (%) | 3 days ago 80% | 3 days ago 72% |
| TrendWeek ODDS (%) | 3 days ago 71% | 3 days ago 77% |
| TrendMonth ODDS (%) | 3 days ago 78% | 3 days ago 83% |
| Advances ODDS (%) | 7 days ago 79% | 14 days ago 79% |
| Declines ODDS (%) | 3 days ago 67% | 5 days ago 76% |
| BollingerBands ODDS (%) | 3 days ago 74% | 3 days ago 69% |
| Aroon ODDS (%) | 3 days ago 63% | 3 days ago 84% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GKOS’s FA Score shows that 0 FA rating(s) are green while NTRA’s FA Score has 3 green FA rating(s).
- GKOS’s FA Score: 0 green, 5 red.
- NTRA’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GKOS’s TA Score shows that 4 TA indicator(s) are bullish while NTRA’s TA Score has 3 bullish TA indicator(s).
- GKOS’s TA Score: 4 bullish, 6 bearish.
- NTRA’s TA Score: 3 bullish, 5 bearish.
Price Growth
GKOS (@Medical/Nursing Services) experienced а -0.51% price change this week, while NTRA (@Medical Specialties) price change was -1.81% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -6.10%. For the same industry, the average monthly price growth was -8.07%, and the average quarterly price growth was -16.10%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -6.45%. For the same industry, the average monthly price growth was -5.12%, and the average quarterly price growth was +31.53%.
Reported Earning Dates
GKOS is expected to report earnings on Oct 28, 2026.
NTRA is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Medical/Nursing Services (-6.10% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Medical Specialties (-6.45% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IWD | 255.77 | -0.35 | -0.14% |
| iShares Russell 1000 Value ETF (IWD) | |||
| DDFJ | 20.15 | -0.06 | -0.30% |
| Innovator Equity Dual Directional 15 Buffer ETF - January (DDFJ) | |||
| CRF | 5.90 | -0.03 | -0.51% |
| Cornerstone Total Return Fund | |||
| DLAG | 33.73 | -0.21 | -0.62% |
| FT Vest U.S. Equity Dual Directional Buffer ETF - August (DLAG) | |||
| FAI | 53.36 | -2.47 | -4.42% |
| First Trust Exchange-Traded Fund II | |||
GKOS and
Correlation & Price change
A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ISRG. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ISRG could also see price increases.
| Ticker / NAME | Correlation To GKOS | 1D Price Change % | ||
|---|---|---|---|---|
| GKOS | 100% | -0.46% | ||
| ISRG - GKOS | 51% Loosely correlated | -0.27% | ||
| NTRA - GKOS | 48% Loosely correlated | -2.80% | ||
| RDNT - GKOS | 48% Loosely correlated | -2.29% | ||
| TWST - GKOS | 46% Loosely correlated | -8.13% | ||
| ALGN - GKOS | 43% Loosely correlated | -1.36% | ||
More | ||||